Chap. 13 Key Terms Word Scramble
|
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
| Term | Definition |
| acetylcholine (Ach) | primary neurotransmitter of the sympathetic nervous system; also present in somatic neuromuscular junctions and at sympathetic preganglionic nerves |
| acetylcholinesterase (AchE) | enzyme that degrades acetylcholine within the synaptic cleft, enhancing effects of the neurotransmitter |
| adrenergic | relating to nerves that release norepinephrine or epinephrine |
| adrenergic antagonist | drug that blocks the actions of the sympathetic nervous system |
| alpha receptor (a receptor) | type of sub receptor found in the sympathetic nervous system |
| anticholinergic | drug that blocks the actions of the parasympathetic nervous system |
| autonomic nervous system | controls involuntary responses by influencing organs, glands, and smooth muscle |
| beta receptor | type of sub receptor found in the sympathetic nervous system |
| catecholamines | class of agents secreted in response to stress that include norepinephrine (NE), epinephrine (adrenalin) and dopamine |
| central nervous system (CNS) | receives and processes information; initiates action |
| cholinergic | relating to nerves that release acetylcholine (Ach) |
| fight-or-flight response | characteristic set of signs and symptoms produced when the sympathetic nervous system is activated |
| ganglionic synapse | region where two neurons meet in a ganglion |
| monoamine oxidase (MAO) | enzyme that destroys norepinephrine (NE) in the nerve terminal |
| muscarinic | type of cholinergic receptor found in smooth muscle, cardiac muscle, and glands |
| myasthenia gravis | motor disorder caused by a destruction of nicotinic receptors on skeletal muscles and characterized by profound muscular fatigue |
| nicotinic | type of cholinergic receptor found in the sympathetic and parasympathetic nervous systems |
| norepinephrine (NE) | primary neurotransmitter in the sympathetic nervous sytem |
| parasympathetic nervous system | portion of the autonomic nervous system that is active during periods of rest and that results in the rest or relaxation response |
| parasympathomimetic | drug that mimics the actions of the parasympathetic nervous system |
| peripheral nervous system (PNS) | transmits signals between the CNS and the rest of the body |
| postganglionic neuron | neuron that receives an action potential from preganglionic neuron |
| preganglionic neuron | neuron that creates an action potential and sends it to a postganglionic neuron |
| rest-and-digest response | signs and symptoms produced when the parasympathetic nervous system is activated |
| somatic nervous system | controls voluntary movements by activating skeletal muscles |
| sympathetic nervous system | portion of the autonomic nervous system that is active during periods of stress and results in the fight-or-flight response |
| sympatholytic | term referring to inhibition of the sympathetic nervous system; actions opposite of sympathomimetic functions in the body |
| sympathomimetic | drug that stimulates or mimics the sympathetic nervous system |
| synapse | junction between two neurons consisting of a presynaptic nerve, a synaptic cleft, and a postsynaptic nerve |
| synaptic transmission | process by which a neurotransmitter reaches receptors to regenerate the action potential |
Created by:
NursingStudyStack
Popular Pharmacology sets